{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:04:32Z","timestamp":1785521072070,"version":"3.56.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012774","name":"Innovationsfonden","doi-asserted-by":"publisher","award":["7038-00070B"],"award-info":[{"award-number":["7038-00070B"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/14\/59\/31282"],"award-info":[{"award-number":["FS\/14\/59\/31282"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cardiovascular and renal complications are the predominant causes of morbidity and mortality amongst patients with diabetes. Development of novel treatments have been hampered by the lack of available animal models recapitulating the human disease. We hypothesized that experimental diabetes in rats combined with a cardiac or renal stressor, would mimic diabetic cardiomyopathy and nephropathy, respectively. Diabetes was surgically induced in male Sprague Dawley rats by 90% pancreatectomy (Px). Isoprenaline (Iso, 1\u00a0mg\/kg, sc., 10\u00a0days) was administered 5\u00a0weeks after Px with the aim of inducing cardiomyopathy, and cardiac function and remodeling was assessed by echocardiography 10\u00a0weeks after surgery. Left ventricular (LV) fibrosis was quantified by Picro Sirius Red and gene expression analysis. Nephropathy was induced by Px combined with uninephrectomy (Px-UNx). Kidney function was assessed by measurement of glomerular filtration rate (GFR) and urine albumin excretion, and kidney injury was evaluated by histopathology and gene expression analysis. Px resulted in stable hyperglycemia, hypoinsulinemia, decreased C-peptide, and increased glycated hemoglobin (HbA1c) compared with sham-operated controls. Moreover, Px increased heart and LV weights and dimensions and caused a shift from \u03b1-myosin heavy chain (MHC) to \u03b2-MHC gene expression. Isoprenaline treatment, but not Px, decreased ejection fraction and induced LV fibrosis. There was no apparent interaction between Px and Iso treatment. The superimposition of Px and UNx increased GFR, indicating hyperfiltration. Compared with sham-operated controls, Px-UNx induced albuminuria and increased urine markers of kidney injury, including neutrophil gelatinase-associated lipocalin (NGAL) and podocalyxin, concomitant with upregulated renal gene expression of NGAL and kidney injury molecule 1 (KIM-1). Whereas Px and isoprenaline separately produced clinical endpoints related to diabetic cardiomyopathy, the combination of the two did not accentuate disease development. Conversely, Px in combination with UNx resulted in several clinical hallmarks of diabetic nephropathy indicative of early disease development.<\/jats:p>","DOI":"10.1038\/s41598-020-73046-8","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T10:03:01Z","timestamp":1601460181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Rat pancreatectomy combined with isoprenaline or uninephrectomy as models of diabetic cardiomyopathy or nephropathy"],"prefix":"10.1038","volume":"10","author":[{"given":"Louise","family":"Thisted","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette V.","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie A.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross T.","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbeth N.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja X.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Secher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea T.","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian T.","family":"Thrane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben","family":"Skarsfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Jelsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten B.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora E.","family":"Zois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"key":"73046_CR1","doi-asserted-by":"publisher","unstructured":"International Diabetes Federation. IDF Diabetes Atlas - 2019. (2019). https:\/\/doi.org\/10.1289\/image.ehp.v119.i03","DOI":"10.1289\/image.ehp.v119.i03"},{"key":"73046_CR2","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2522\/ptj.20080020","volume":"88","author":"AD Deshpande","year":"2008","unstructured":"Deshpande, A. D., Harris-Hayes, M. & Schootman, M. Epidemiology of diabetes and diabetes-related complications. Phys. Ther. 88, 1254\u20131264 (2008).","journal-title":"Phys. Ther."},{"key":"73046_CR3","unstructured":"Secrest, A.M., Washington, R.E. & Orchard, T.J. Chapter 35: Mortality in Type 1 Diabetes. in Diabetes in America 1\u201316 (2014)."},{"key":"73046_CR4","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.2337\/diacare.26.8.2433","volume":"26","author":"DS Bell","year":"2003","unstructured":"Bell, D. S. Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 26, 2433\u20132441 (2003).","journal-title":"Diabetes Care"},{"key":"73046_CR5","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1093\/eurheartj\/eht142","volume":"34","author":"JA Beckman","year":"2013","unstructured":"Beckman, J. A., Paneni, F., Cosentino, F. & Creager, M. A. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II. Eur. Heart J. 34, 2444\u20132456 (2013).","journal-title":"Eur. Heart J."},{"key":"73046_CR6","doi-asserted-by":"publisher","first-page":"e65174","DOI":"10.1371\/journal.pone.0065174","volume":"8","author":"GM Singh","year":"2013","unstructured":"Singh, G. M. et al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS ONE 8, e65174 (2013).","journal-title":"PLoS ONE"},{"key":"73046_CR7","first-page":"10","volume":"45","author":"S Boudina","year":"2009","unstructured":"Boudina, S. Clinical manifestations of diabetic cardiomyopathy. Hear. Metab. 45, 10\u201314 (2009).","journal-title":"Hear. Metab."},{"key":"73046_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler, S. et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am. J. Cardiol. 30, 595\u2013602 (1972).","journal-title":"Am. J. Cardiol."},{"key":"73046_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000064682","volume":"98","author":"CM Schannwell","year":"2002","unstructured":"Schannwell, C. M., Schneppenheim, M., Perings, S., Plehn, G. & Strauer, B. E. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 98, 33\u201339 (2002).","journal-title":"Cardiology"},{"key":"73046_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/jcp.46.1.32","volume":"46","author":"M Shimizu","year":"1993","unstructured":"Shimizu, M. et al. Collagen remodelling in myocardia of patients with diabetes. J. Clin. Pathol. 46, 32\u201336 (1993).","journal-title":"J. Clin. Pathol."},{"key":"73046_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1042\/CS20040057","volume":"107","author":"SA Hayat","year":"2004","unstructured":"Hayat, S. A., Patel, B., Khattar, R. S. & Malik, R. A. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin. Sci. 107, 539\u2013557 (2004).","journal-title":"Clin. Sci."},{"key":"73046_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000363300","volume":"126","author":"B Betz","year":"2014","unstructured":"Betz, B. & Conway, B. R. Recent advances in animal models of diabetic nephropathy. Nephron Exp. Nephrol. 126, 191\u2013195 (2014).","journal-title":"Nephron Exp. Nephrol."},{"key":"73046_CR13","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/ndt\/12.6.1149","volume":"12","author":"S Rudberg","year":"1997","unstructured":"Rudberg, S. & Osterby, R. Decreasing glomerular filtration rate\u2014an indicator of more advanced diabetic glomerulopathy in the early course of microalbuminuria in IDDM adolescents?. Nephrol. Dial. Transplant. 12, 1149\u20131154 (1997).","journal-title":"Nephrol. Dial. Transplant."},{"key":"73046_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00004872-199204001-00004","volume":"10","author":"SM Mauer","year":"1992","unstructured":"Mauer, S. M., Lane, P., Zhu, D., Fioretto, P. & Steffes, M. W. Renal structure and function in insulin-dependent diabetes mellitus in man. J. Hypertens. Suppl. 10, 17\u201320 (1992).","journal-title":"J. Hypertens. Suppl."},{"key":"73046_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1681\/ASN.2004080648","volume":"16","author":"MD Breyer","year":"2005","unstructured":"Breyer, M. D. et al. Mouse models of diabetic nephropathy. J. Am. Soc. Nephrol. 16, 27\u201345 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"73046_CR16","unstructured":"AMDCC. Validation of Models of Cardiovascular Disease in Diabetes. 1\u201313 (2003)."},{"key":"73046_CR17","unstructured":"AMDCC. Validation of Mouse Models of Diabetic Nephropathy. 1\u201312 (2003)."},{"key":"73046_CR18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s12265-012-9388-1","volume":"5","author":"HD Nickerson","year":"2012","unstructured":"Nickerson, H. D. & Dutta, S. Diabetic complications: Current challenges and opportunities. J. Cardiovasc. Transl. Res. 5, 375\u2013379 (2012).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"73046_CR19","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/sj.bjp.0704131","volume":"133","author":"G Miric","year":"2001","unstructured":"Miric, G. et al. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br. J. Pharmacol. 133, 687\u2013694 (2001).","journal-title":"Br. J. Pharmacol."},{"key":"73046_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0014-2999(00)00320-4","volume":"398","author":"M Katoh","year":"2000","unstructured":"Katoh, M. et al. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice. Eur. J. Pharmacol. 398, 381\u2013387 (2000).","journal-title":"Eur. J. Pharmacol."},{"key":"73046_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1590\/2359-3997000000188","volume":"60","author":"SM Fernandes","year":"2016","unstructured":"Fernandes, S. M. et al. The role of oxidative stress in streptozotocin-induced diabetic nephropathy in rats. Arch. Endocrinol. Metab. 60, 443\u2013449 (2016).","journal-title":"Arch. Endocrinol. Metab."},{"key":"73046_CR22","doi-asserted-by":"publisher","first-page":"e14333","DOI":"10.14814\/phy2.14333","volume":"7","author":"FE Sembach","year":"2019","unstructured":"Sembach, F. E. et al. Impact of sex on diabetic nephropathy and the renal transcriptome in UNx db\/db C57BLKS mice. Physiol. Rep. 7, e14333 (2019).","journal-title":"Physiol. Rep."},{"key":"73046_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12933-019-0980-4","volume":"19","author":"M Arow","year":"2020","unstructured":"Arow, M. et al. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy. Cardiovasc. Diabetol. 19, 7 (2020).","journal-title":"Cardiovasc. Diabetol."},{"key":"73046_CR24","first-page":"579","volume":"512","author":"AD Bolz\u00e1n","year":"2002","unstructured":"Bolz\u00e1n, A. D. & Bianchi, M. S. Genotoxicity of streptozotocin. Diabetes 512, 579\u2013582 (2002).","journal-title":"Diabetes"},{"key":"73046_CR25","first-page":"70","volume":"6","author":"P Camacho","year":"2016","unstructured":"Camacho, P., Fan, H., Liu, Z. & He, J. Q. Small mammalian animal models of heart disease. Am. J. Cardiovasc. Dis. 6, 70\u201380 (2016).","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"73046_CR26","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1242\/dmm.001941","volume":"2","author":"H Bugger","year":"2009","unstructured":"Bugger, H. & Abel, E. D. Rodent models of diabetic cardiomyopathy. Dis. Model. Mech. 2, 454\u2013466 (2009).","journal-title":"Dis. Model. Mech."},{"key":"73046_CR27","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1590\/S0102-865020160100000010","volume":"31","author":"JMR Eul\u00e1lio","year":"2016","unstructured":"Eul\u00e1lio, J. M. R. et al. Critical analysis and systematization of rat pancreatectomy terminology. Acta Cir. Bras. 31, 698\u2013704 (2016).","journal-title":"Acta Cir. Bras."},{"key":"73046_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00006676-199707000-00008","volume":"15","author":"K Tanigawa","year":"1997","unstructured":"Tanigawa, K. et al. Effect of aging on B-cell function and replication in rat pancreas after 90% pancreatectomy. Pancreas 15, 53\u201359 (1997).","journal-title":"Pancreas"},{"key":"73046_CR29","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/S1071-9164(99)91337-4","volume":"5","author":"BD Hoit","year":"1999","unstructured":"Hoit, B. D., Castro, C., Bultron, G., Knight, S. & Matlib, M. A. Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocin-induced diabetic rats. J. Card. Fail. 5, 324\u2013333 (1999).","journal-title":"J. Card. Fail."},{"key":"73046_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0008-6363(97)00212-5","volume":"37","author":"D Grimm","year":"1998","unstructured":"Grimm, D. et al. Development of heart failure following isoproterenol administration in the rat: role of the renin\u2013angiotensin system. Cardiovasc. Res. 37, 91\u2013100 (1998).","journal-title":"Cardiovasc. Res."},{"key":"73046_CR31","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1152\/ajpheart.2001.281.6.H2410","volume":"281","author":"FH Leenen","year":"2001","unstructured":"Leenen, F. H., White, R. & Yuan, B. Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin\u2013angiotensin system. Am. J. Physiol. Hear. Circ. Physiol. 281, 2410\u20132416 (2001).","journal-title":"Am. J. Physiol. Hear. Circ. Physiol."},{"key":"73046_CR32","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1159\/000327586","volume":"119","author":"S Zheng","year":"2011","unstructured":"Zheng, S. et al. Uninephrectomy of diabetic OVE26 mice greatly accelerates albuminuria, fibrosis, inflammatory cell infiltration and changes in gene expression. Nephron Exp. Nephrol. 119, e21\u2013e32 (2011).","journal-title":"Nephron Exp. Nephrol."},{"key":"73046_CR33","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1038\/s41598-018-23839-9","volume":"8","author":"M Uil","year":"2018","unstructured":"Uil, M. et al. Combining streptozotocin and unilateral nephrectomy is an effective method for inducing experimental diabetic nephropathy in the \u2018resistant\u2019 C57Bl\/6J mouse strain OPEN. Sci. Rep. 8, 5542 (2018).","journal-title":"Sci. Rep."},{"key":"73046_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.echo.2014.11.015","volume":"28","author":"SA Goldstein","year":"2015","unstructured":"Goldstein, S. A. et al. Multimodality imaging of diseases of the thoracic aorta in adults: from the American society of echocardiography and the European Association of cardiovascular imaging: endorsed by the society of cardiovascular computed tomography and society for cardiova. J. Am. Soc. Echocardiogr. 28, 119\u2013182 (2015).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"73046_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0002-9149(76)90491-4","volume":"37","author":"LE Teichholz","year":"1976","unstructured":"Teichholz, L. E., Herman, V., Kreulen, T. & Gorlin, R. Problems in echocardiographic presence or absence volume determinations: correlations in the of asynergy. Am. J. Cardiol. 37, 7\u201311 (1976).","journal-title":"Am. J. Cardiol."},{"key":"73046_CR36","first-page":"1","volume":"75","author":"T Rieg","year":"2013","unstructured":"Rieg, T. A High-throughput method for measurement of glomerular filtration rate in conscious mice. J. Vis. Exp. 75, 1\u20136 (2013).","journal-title":"J. Vis. Exp."},{"key":"73046_CR37","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/j.1469-7580.2010.01285.x","volume":"217","author":"SJ Paulsen","year":"2010","unstructured":"Paulsen, S. J., Vrang, N., Larsen, L. K., Larsen, P. J. & Jelsing, J. Stereological assessment of pancreatic beta-cell mass development in male Zucker Diabetic Fatty (ZDF) rats: correlation with pancreatic beta-cell function. J. Anat. 217, 624\u2013630 (2010).","journal-title":"J. Anat."},{"key":"73046_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-1-61779-851-1_10","volume":"886","author":"LA Cullen-Mcewen","year":"2012","unstructured":"Cullen-Mcewen, L. A., Armitage, J. A., Nyengaard, J. R. & Bertram, J. F. Estimating nephron number in the developing kidney using the physical disector\/fractionator combination. Methods Mol. Biol. 886, 109\u2013119 (2012).","journal-title":"Methods Mol. Biol."},{"key":"73046_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"73046_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 1\u201321 (2014).","journal-title":"Genome Biol."},{"key":"73046_CR41","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1152\/ajpendo.2000.279.1.E68","volume":"279","author":"YQ Liu","year":"2000","unstructured":"Liu, Y. Q., Nevin, P. W. & Leahy, J. L. \u03b2-Cell adaptation in 60% pancreatectomy rats that preserves normoinsulinemia and normoglycemia. Am. J. Physiol. Endocrinol. Metab. 279, 68\u201373 (2000).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"73046_CR42","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2015.216","volume":"12","author":"G Jia","year":"2016","unstructured":"Jia, G., Demarco, V. G. & Sowers, J. R. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy HHS Public Access. Nat. Rev. Endocrinol. 12, 144\u2013153 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"73046_CR43","first-page":"1","volume":"54","author":"J Hotz","year":"2005","unstructured":"Hotz, J., Oberna, R. G. & Clodi, P. H. Reserve capacity of the exocrine pancreas enzyme secretion and fecal fat assimilation in the 95% pancrcatectomized rat. Gut 54, 1\u201328 (2005).","journal-title":"Gut"},{"key":"73046_CR44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.33549\/physiolres.931556","volume":"57","author":"E Kr\u00e1lov\u00e1","year":"2008","unstructured":"Kr\u00e1lov\u00e1, E., Mokr\u00e1n, T., Mur\u00edn, J. & Stankovicov\u00e1, T. Electrocardiography in two models of isoproterenol-induced left ventricular remodeling. Physiol. Res. 57, 83\u201389 (2008).","journal-title":"Physiol. Res."},{"key":"73046_CR45","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1161\/01.RES.65.3.657","volume":"65","author":"IJ Benjamin","year":"1989","unstructured":"Benjamin, I. J. et al. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ. Res. 65, 657\u2013670 (1989).","journal-title":"Circ. Res."},{"key":"73046_CR46","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1152\/ajpheart.1994.267.4.H1496","volume":"267","author":"E Golomb","year":"1994","unstructured":"Golomb, E. et al. Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats. Am. J. Physiol. Hear. Circ. Physiol. 267, 1496\u20131506 (1994).","journal-title":"Am. J. Physiol. Hear. Circ. Physiol."},{"key":"73046_CR47","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner, S. M., Lehto, S., R\u00f6nnemaa, T., Py\u00f6r\u00e4l\u00e4, K. & Laakso, M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339, 229\u2013234 (1998).","journal-title":"N. Engl. J. Med."},{"key":"73046_CR48","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/hrt.2003.032797","volume":"91","author":"R Fazel","year":"2005","unstructured":"Fazel, R., Fang, J., Kline-Rogers, E. & Smith, D. E. Prognostic value of elevated biomarkers in diabetic and non-diabetic patients admitted for acute coronary syndromes. Heart 91, 388\u2013390 (2005).","journal-title":"Heart"},{"key":"73046_CR49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.stem.2015.04.020","volume":"17","author":"H Wu","year":"2015","unstructured":"Wu, H. et al. Epigenetic regulation of phosphodiesterases 2A and 3A underlies compromised \u03b2-adrenergic signaling in an iPSC model of dilated cardiomyopathy. Cell Stem Cell 17, 89\u2013100 (2015).","journal-title":"Cell Stem Cell"},{"key":"73046_CR50","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1161\/01.CIR.99.24.3099","volume":"99","author":"DM Roth","year":"1999","unstructured":"Roth, D. M. et al. Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy. Circ. J. 99, 3099\u20133102 (1999).","journal-title":"Circ. J."},{"key":"73046_CR51","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1681\/ASN.2016060666","volume":"28","author":"L Tonneijck","year":"2017","unstructured":"Tonneijck, L. et al. Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. J. Am. Soc. Nephrol. 28, 1023\u20131039 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"73046_CR52","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","volume":"62","author":"WK Han","year":"2002","unstructured":"Han, W. K., Bailly, V., Abichandani, R., Thadhani, R. & Bonventre, J. V. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 62, 237\u2013244 (2002).","journal-title":"Kidney Int."},{"key":"73046_CR53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/00365510802150158","volume":"68","author":"P Devarajan","year":"2008","unstructured":"Devarajan, P. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand. J. Clin. Lab. Invest. 68, 89\u201394 (2008).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"73046_CR54","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12933-016-0359-8","volume":"15","author":"AC Carlsson","year":"2016","unstructured":"Carlsson, A. C. et al. Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes Open Access. Cardiovasc. Diabetol. 15, 40 (2016).","journal-title":"Cardiovasc. Diabetol."},{"key":"73046_CR55","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1007\/s00125-012-2661-7","volume":"55","author":"M Hara","year":"2012","unstructured":"Hara, M. et al. Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: Establishment of a highly sensitive ELISA to detect urinary podocalyxin. Diabetologia 55, 2913\u20132919 (2012).","journal-title":"Diabetologia"},{"key":"73046_CR56","doi-asserted-by":"publisher","first-page":"F194","DOI":"10.1152\/ajprenal.00520.2013","volume":"306","author":"V Vallon","year":"2014","unstructured":"Vallon, V. et al. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice. Am. J. Physiol. Ren. Physiol. 306, F194 (2014).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"73046_CR57","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.2337\/db11-1824","volume":"61","author":"A Mima","year":"2012","unstructured":"Mima, A. et al. Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKC\u03b2 activation in diabetes. Diabetes 61, 2967\u20132979 (2012).","journal-title":"Diabetes"},{"key":"73046_CR58","doi-asserted-by":"publisher","first-page":"469","DOI":"10.34067\/KID.0001272019","volume":"1","author":"MV \u00d8stergaard","year":"2020","unstructured":"\u00d8stergaard, M. V. et al. Automated image analyses of glomerular hypertrophy in a mouse model of diabetic nephropathy. Kidney360 1, 469\u2013479 (2020).","journal-title":"Kidney360"},{"key":"73046_CR59","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/01.HYP.0000060689.38912.CB","volume":"41","author":"C Tikellis","year":"2003","unstructured":"Tikellis, C. et al. Characterization of renal angiotensin\u2014converting enzyme 2 in diabetic nephropathy. Hypertension 41, 392\u2013397 (2003).","journal-title":"Hypertension"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73046-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73046-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73046-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:19:11Z","timestamp":1670357951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73046-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["73046"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-73046-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]},"assertion":[{"value":"6 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.T., M.V.O., A.A.P., P.J.P., L.N.F., T.Se., S.T.T., J.J., N.E.Z. are employed by Gubra. The rest of the authors declare to have no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16130"}}